Physician profile
Antonino Carlino
NPI 1770602377
$6,873.95
in general payments reported to CMS, 2019-2025
39 companies · $810 in 2025
The $810 reported for 2025 was more than what 97% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $1,259 · 2021: $2,270 · 2022: $1,446 · 2023: $369 · 2024: $216 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,287.58 | 2019-2025 | Uplizna |
| Boston Scientific Corporation | $971.62 | 2019-2022 | |
| Abbvie INC. | $450.05 | 2021-2025 | Botox |
| Scilex Pharmaceuticals INC. | $422.34 | 2019-2022 | |
| Saluda Medical Americas, INC. | $374.86 | 2025 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $356.29 | 2019-2023 | Relistor |
| Relievant Medsystems, INC. | $323.27 | 2021-2022 | |
| Biogen, INC. | $319.41 | 2019-2023 | Vumerity, Tysabri |
| Vanda Pharmaceuticals INC. | $297.58 | 2022-2023 | Hetlioz |
| Vertex Pharmaceuticals Incorporated | $189.04 | 2025 | |
| Nevro Corp. | $161.77 | 2021 | |
| Abbott Laboratories | $151.53 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $149.20 | 2020-2021 | |
| Foundation Fusion Solutions, LLC | $129.90 | 2022-2024 | |
| Biodelivery Sciences International, INC. | $125.00 | 2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $124.99 | 2021 | |
| Grt US Holding, INC. | $121.64 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $111.10 | 2019 | |
| Impel Pharmaceuticals INC. | $104.94 | 2022 | |
| Assertio Therapeutics, INC. | $86.05 | 2020 | |
| Vertos Medical, INC. | $74.54 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.10 | 2025 | Hyqvia |
| Nalu Medical, INC. | $58.00 | 2021 | |
| Amneal Pharmaceuticals LLC | $50.27 | 2021-2023 | Lyvispah |
| Si-Bone, INC. | $45.59 | 2022-2024 | |
| Spr Therapeutics, INC | $44.36 | 2024 | Sprint Pns System |
| Allergan, INC. | $39.50 | 2020 | |
| Promius Pharma LLC | $34.67 | 2019 | |
| Genzyme Corporation | $25.22 | 2020 | |
| Banner Life Sciences, LLC | $24.39 | 2022 | |
| Zyla Life Sciences, INC. | $23.96 | 2020 | |
| Redhill Biopharma INC. | $22.40 | 2020 | |
| Alk-Abello, INC | $17.57 | 2025 | Grastek, Odactra, Ragwitek |
| Corcept Therapeutics | $17.33 | 2025 | Korlym |
| Almatica Pharma LLC | $16.99 | 2023 | Gralise |
| Pacira Pharmaceuticals Incorporated | $16.86 | 2020 | |
| Baudax Bio INC. | $15.41 | 2022 | |
| International Rehabilitative Sciences, INC | $13.67 | 2022 | |
| Medtronic, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonino Carlino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.